Motor Task Practice for Hemiparesis
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment No Practice Variable, Practice Variable for hemiparesis?
Research shows that repetitive task-specific practice, especially when combined with electrical stimulation and behavioral supports, can significantly reduce impairment in stroke survivors with moderate upper extremity deficits. This suggests that practice-based treatments may be effective for improving motor function in individuals with hemiparesis.12345
Is motor task practice for hemiparesis safe for humans?
How does the treatment 'Motor Task Practice for Hemiparesis' differ from other treatments for hemiparesis?
This treatment is unique because it focuses on task-specific motor learning, which can stimulate neuroplastic changes in the brain, helping to reorganize and improve motor function after a stroke. Unlike general arm use, task-specific practice has been shown to facilitate motor learning and alter brain activity patterns, potentially leading to better recovery outcomes.29101112
What is the purpose of this trial?
The purpose of this research is to learn about practice conditions that may benefit stroke survivors when learning to use their more affected arm to perform a task. Participants will be randomized into two groups. Experimental and control groups will differ by one practice variable that will not be disclosed until completion of testing procedures. Participants will practice a motor task using both their more and less affected arms for two consecutive days. A Pre-Test will be administered on Day 1 before the training begins. Immediate Transfer of Learning will be administered on Day 2 after the completion of training. Delayed (24-hour) Retention and Transfer Tests will be administered on Day 3.
Research Team
Dawn Nilsen, EdD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for stroke survivors with upper limb weakness who can follow commands and have had a stroke at least 6 months ago. They should be able to speak English, have not received Botox in the last 3 months, and not currently be in upper limb therapy. Severe neglect or arm pain that limits movement disqualifies participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Test
A Pre-Test is administered on Day 1 before the training begins
Training
Participants practice a motor task using both their more and less affected arms for two consecutive days
Immediate Transfer Test
Immediate Transfer of Learning is administered on Day 2 after the completion of training
Follow-up
Delayed (24-hour) Retention and Transfer Tests are administered on Day 3
Treatment Details
Interventions
- No Practice Variable
- Practice Variable
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor